Information Provided By:
Fly News Breaks for July 29, 2019
GHDX, EXAS
Jul 29, 2019 | 12:41 EDT
JPMorgan analyst Tycho Peterson upgraded Genomic Health (GHDX) to Neutral from Underweight and raised his price target for the shares to $72 from $60 after the company reached an agreement to be acquired by Exact Sciences (EXAS).
News For GHDX;EXAS From the Last 2 Days
There are no results for your query GHDX;EXAS